scPharmaceuticals/SCPH

$4.56

1.1%
-
1D1W1MYTD1YMAX

About scPharmaceuticals

scPharmaceuticals Inc. is a pharmaceutical company. The Company is focused on developing and commercializing products to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The Company develops, internally and through strategic partnerships, products and solutions that aim to expand and advance the outpatient care of select acute conditions. Its lead product candidate, FUROSCIX, consists of its formulation of furosemide delivered via an on-body infuser. FUROSCIX is a formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self- administered subcutaneously via a single-use, disposable and wearable on-body delivery system. The Companay’s pipeline programs include SCP-111 (furosemide injection) 80mg/mL is an investigational pH neutral aqueous furosemide formulation that is being developed for subcutaneous administration outside of the hospital setting, including patient self-administration in the home.

Ticker

SCPH

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

John Tucker

Employees

135

Headquarters

Burlington, United States

SCPH Metrics

BasicAdvanced
$162.61M
Market cap
-
P/E ratio
-$1.42
EPS
0.09
Beta
-
Dividend rate
$162.61M
0.08725
$12.75
$4.25
232.84K
7.076
6.403
104.28
104.28
-18.35%
-50.13%
-99.97%
-55.33%
11.962
4.359
4.369
-9.11%

What the Analysts think about SCPH

Analyst Ratings

Majority rating from 6 analysts.
Buy

Price Targets

Average projection from 6 analysts.
327.63% upside
High $25.00
Low $16.00
$4.56
Current price
$19.50
Average price target

SCPH Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-230% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$6M
62.16%
Net income
$-13.8M
-11.54%
Profit margin
-230%
-45.45%

SCPH Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 16.43%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.30
-$0.36
-$0.41
-$0.35
-
Expected
-$0.37
-$0.37
-$0.36
-$0.42
-$0.44
Surprise
-17.81%
-3.33%
12.38%
-16.43%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for scPharmaceuticals stock?

scPharmaceuticals (SCPH) has a market cap of $164.41M as of April 21, 2024.

What is the P/E ratio for scPharmaceuticals stock?

The price to earnings (P/E) ratio for scPharmaceuticals (SCPH) stock is 0 as of April 21, 2024.

Does scPharmaceuticals stock pay dividends?

No, scPharmaceuticals (SCPH) stock does not pay dividends to its shareholders as of April 21, 2024.

When is the next scPharmaceuticals dividend payment date?

scPharmaceuticals (SCPH) stock does not pay dividends to its shareholders.

What is the beta indicator for scPharmaceuticals?

scPharmaceuticals (SCPH) has a beta rating of 0.09. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the scPharmaceuticals stock price target?

The target price for scPharmaceuticals (SCPH) stock is $19.5, which is 327.63% above the current price of $4.56. This is an average based on projections from 6 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell scPharmaceuticals stock

Buy or sell scPharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing